Literature DB >> 31974747

[Bone tumors and metastases: tips for initial diagnosis and follow-up : Update 2019].

Kolja M Thierfelder1, Sophie Niendorf2, Judith S Gerhardt2, Marc-An Dré Weber2.   

Abstract

Benign bone tumors are frequently discovered as incidental findings, whereas malignant tumors and metastases often become clinically noticeable due to pain or swelling. The initial radiological diagnostics by conventional X‑ray imaging, magnetic resonance imaging (MRI) and computed tomography (CT) play an important role in the assessment of dignity and further treatment planning. The aftercare of bone tumors is necessary for the recognition of recurrences and distant metastases as well as the detection of complications, e.g. after implantation of a prosthesis. Implanted metal and posttherapeutic alterations can impede the aftercare due to artifacts and treatment-associated tissue alterations. In addition to the recommendations of the Association of the Scientific Medical Societies in Germany (AWMF), the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Musculoskeletal Radiology (ESSR), study protocols can be used as orientation for the aftercare of individual primary malignant bone tumors.

Entities:  

Keywords:  Aftercare; Bone neoplasms; Computed tomography; Magnetic resonance imaging; X‑rays

Mesh:

Year:  2020        PMID: 31974747     DOI: 10.1007/s00117-019-00635-8

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  26 in total

1.  Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P G Casali; S Bielack; N Abecassis; H T Aro; S Bauer; R Biagini; S Bonvalot; I Boukovinas; J V M G Bovee; B Brennan; T Brodowicz; J M Broto; L Brugières; A Buonadonna; E De Álava; A P Dei Tos; X G Del Muro; P Dileo; C Dhooge; M Eriksson; F Fagioli; A Fedenko; V Ferraresi; A Ferrari; S Ferrari; A M Frezza; N Gaspar; S Gasperoni; H Gelderblom; T Gil; G Grignani; A Gronchi; R L Haas; B Hassan; S Hecker-Nolting; P Hohenberger; R Issels; H Joensuu; R L Jones; I Judson; P Jutte; S Kaal; L Kager; B Kasper; K Kopeckova; D A Krákorová; R Ladenstein; A Le Cesne; I Lugowska; O Merimsky; M Montemurro; B Morland; M A Pantaleo; R Piana; P Picci; S Piperno-Neumann; A L Pousa; P Reichardt; M H Robinson; P Rutkowski; A A Safwat; P Schöffski; S Sleijfer; S Stacchiotti; S J Strauss; K Sundby Hall; M Unk; F Van Coevorden; W T A van der Graaf; J Whelan; E Wardelmann; O Zaikova; J Y Blay
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976

2.  Diagnostic Value of Plain Radiography for Symptomatic Bone Metastasis at the First Visit.

Authors:  Yasuyuki Kitagawa; Takashi Yamaoka; Mari Yokouchi; Toshihiko Ito; Yoshihiro Mizuno; Yoshihiro Sudo; Yong Kim; Ryu Tsunoda; Shinro Takai
Journal:  J Nippon Med Sch       Date:  2018       Impact factor: 0.920

3.  18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT.

Authors:  Andrei Samarin; Martin Hüllner; Marcelo A Queiroz; Paul Stolzmann; Irene A Burger; Gustav von Schulthess; Patrick Veit-Haibach
Journal:  Nucl Med Commun       Date:  2015-12       Impact factor: 1.690

4.  ESSR Consensus Document for Detection, Characterization, and Referral Pathway for Tumors and Tumorlike Lesions of Bone.

Authors:  Radhesh Lalam; Johan L Bloem; Iris M Noebauer-Huhmann; Klaus Wörtler; Alberto Tagliafico; Filip Vanhoenacker; Violeta Vasilevska Nikodinovska; Hatice Tuba Sanal; Henk-Jan van der Woude; Olympia Papakonstantinou; Gunnar Åström; Mark Davies; Amanda Isaac; Marc-André Weber
Journal:  Semin Musculoskelet Radiol       Date:  2017-10-12       Impact factor: 1.777

Review 5.  Practical Input on Bone Tumor Imaging: Pathological Fracture, Risk Features, and When to Contact Orthopaedics.

Authors:  Magdalena Lunkiewicz; Suzanne Anderson; Sina Havakeshian; Andreas Würzburg
Journal:  Semin Musculoskelet Radiol       Date:  2019-01-30       Impact factor: 1.777

6.  Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.

Authors:  Yoshiko Hayashida; Toshitake Yakushiji; Kazuo Awai; Kazuhiro Katahira; Yoshiharu Nakayama; Osamu Shimomura; Mika Kitajima; Toshinori Hirai; Yasuyuki Yamashita; Hiroshi Mizuta
Journal:  Eur Radiol       Date:  2006-08-15       Impact factor: 5.315

7.  Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

Authors:  M Schulte; D Brecht-Krauss; M Werner; E Hartwig; M R Sarkar; P Keppler; J Kotzerke; A Guhlmann; G Delling; S N Reske
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

8.  Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.

Authors:  C Franzius; J Sciuk; C Brinkschmidt; H Jürgens; O Schober
Journal:  Clin Nucl Med       Date:  2000-11       Impact factor: 7.794

Review 9.  [Postoperative and posttherapeutic changes after primary bone tumors : What's important for radiologists?]

Authors:  T Grieser; I-M Nöbauer-Huhmann
Journal:  Radiologe       Date:  2017-11       Impact factor: 0.635

10.  Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients.

Authors:  O A Catalano; E Nicolai; B R Rosen; A Luongo; M Catalano; C Iannace; A Guimaraes; M G Vangel; U Mahmood; A Soricelli; M Salvatore
Journal:  Br J Cancer       Date:  2015-04-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.